Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Machine Learning and Expert Sensory Evaluation to Identify Key Drivers of Tomato Fruit Quality: A Multi-Model and Age-Stratified Analysis.

Foods (Basel, Switzerland)·2026
Same author

Covalent Ag-holey MXene link at interface boosting electrochemical dechlorination.

Nature communications·2026
Same author

Fermentation strategies, bioactive component regulation mechanisms, and health-promoting effects of medicine and food homology: A review.

Food microbiology·2026
Same author

Counterion effect on boundary lubrication of cationic surfactant at mica-water interface.

Journal of colloid and interface science·2026
Same author

Mechanisms of enhanced sesame protein recovery via cold plasma pretreatment: Impact of surface etching and oxidative hydrophilization.

Food research international (Ottawa, Ont.)·2026
Same author

Irisin and anxiety-like behaviors: Mechanistic integration of peripheral-central crosstalk, neuroinflammation, and neural plasticity.

Neuroscience and biobehavioral reviews·2026

Related Experiment Video

Updated: May 10, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.7K

Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors.

Zhehao Fan1,2, Xiaofeng Liu3, Ning Wang1,2

  • 1Institute of Translational Medicine, Medical College, Yangzhou University, Jiangyangzhonglu No. 136, Yangzhou, Jiangsu, China.

Journal of Cancer Research and Clinical Oncology
|May 15, 2024
PubMed
Summary

Researchers identified ZINC10039815 as a potent inhibitor of lysine-specific demethylase 1 (LSD1), a key target in cancer therapy. This compound shows promise for developing new anti-cancer drugs by blocking LSD1 activity.

Keywords:
DockingInhibitorLSD1Molecular dynamics simulation

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.2K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

257

Related Experiment Videos

Last Updated: May 10, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.7K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.2K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

257

Area of Science:

  • Biochemistry
  • Epigenetics
  • Drug Discovery

Background:

  • Lysine-specific demethylase 1 (LSD1) is highly expressed in various cancers.
  • LSD1 is a critical epigenetic target for anti-tumor therapies.
  • Inhibiting LSD1 activity offers a promising strategy for targeted cancer treatment.

Purpose of the Study:

  • To identify novel inhibitors of LSD1 using structure-based drug design.
  • To evaluate potential compounds for their ability to inhibit LSD1 activity.

Main Methods:

  • Utilized structure-based drug design and virtual docking from the ZINC15 database.
  • Employed molecular dynamic simulations and biochemical experiments to analyze binding interactions.

Main Results:

  • ZINC10039815 demonstrated an excellent binding mode within the LSD1 active pocket.
  • The compound formed strong interactions with critical LSD1 residues.

Conclusions:

  • ZINC10039815 exhibits significant inhibitory effects on LSD1 activity.
  • ZINC10039815 is a promising candidate for developing novel LSD1 inhibitors for cancer therapy.